Skip to main content
Top
Published in: BMC Cancer 1/2018

Open Access 01-12-2018 | Research article

Incidence and histological patterns of thyroid cancer in Sri Lanka 2001-2010: an analysis of national cancer registry data

Authors: Umesh Jayarajah, Ashan Fernando, Saumyakala Prabashani, Eshani A. Fernando, Sanjeewa A. Seneviratne

Published in: BMC Cancer | Issue 1/2018

Login to get access

Abstract

Background

An increasing incidence of thyroid cancer is observed in many developed countries. Increasing incidence may also reflect better reporting or increased diagnostic scrutiny. We conducted this study to examine trends in thyroid cancer incidence and histological patterns in Sri Lanka.

Methods

A retrospective cohort evaluation of patients with thyroid cancer during 2001–2010 was performed using population based data published from the Sri Lanka National Cancer Registry. Trends in incidence and histological patterns were analysed by age and gender.

Results

The age-standardized incidence of thyroid cancer increased from 2.44 per 100,000 in 2001 (95% confidence interval [95% CI]: 2.21–2.67) to 5.16 per 100,000 in 2010 (95% CI: 4.85–5.47); a 2.1-fold increase (p < 0.05 for trend). A greater part of this increase is attributable to increase in incidence of papillary thyroid cancer, which increased from 1.64 to 3.61 per 100,000; a 2.2-fold increase (p < 0.05 for trend). Follicular cancer showed lesser, yet a significant increase from 0.56 to 0.95 per 100,000 (p < 0.05). Other varieties of thyroid cancer showed no significant increases in incidence. Trends in the increases in incidence of papillary cancer in females showed a much greater increase compared with males (from 2.45 to 5.60 per 100,000, a 2.28-fold increase in females compared with from 0.82 to 1.55; a 1.89-fold increase in males, p < 0.001). Highest incidence of papillary cancer was observed in 30–39-year age group, which has increased from 5.56 to 12.9 per 100,000; a 2.32-fold increase (p < 0.001).

Conclusions

The increasing incidence of thyroid cancer in Sri Lanka is predominantly due to the increasing incidence of papillary cancers. These trends may reflect increased detection and better reporting, although an inherent increase in the incidence is the likely main contributor. Further studies including tumour stage and mortality may help answer these questions.
Literature
1.
go back to reference National Cancer Control Programme Sri Lanka: Cancer incidence data, Sri Lanka 2001–2010. Colombo: Ministry of Health; 2016. National Cancer Control Programme Sri Lanka: Cancer incidence data, Sri Lanka 2001–2010. Colombo: Ministry of Health; 2016.
2.
go back to reference Davies L, Welch HG. Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA. 2006;295(18):2164–7.CrossRefPubMed Davies L, Welch HG. Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA. 2006;295(18):2164–7.CrossRefPubMed
3.
go back to reference Liu S, Semenciw R, Ugnat A, Mao Y. Increasing thyroid cancer incidence in Canada, 1970–1996: time trends and age-period-cohort effects. Br J Cancer. 2001;85(9):1335.CrossRefPubMedPubMedCentral Liu S, Semenciw R, Ugnat A, Mao Y. Increasing thyroid cancer incidence in Canada, 1970–1996: time trends and age-period-cohort effects. Br J Cancer. 2001;85(9):1335.CrossRefPubMedPubMedCentral
4.
go back to reference Grodski S, Brown T, Sidhu S, Gill A, Robinson B, Learoyd D, Sywak M, Reeve T, Delbridge L. Increasing incidence of thyroid cancer is due to increased pathologic detection. Surgery. 2008;144(6):1038–43.CrossRefPubMed Grodski S, Brown T, Sidhu S, Gill A, Robinson B, Learoyd D, Sywak M, Reeve T, Delbridge L. Increasing incidence of thyroid cancer is due to increased pathologic detection. Surgery. 2008;144(6):1038–43.CrossRefPubMed
5.
6.
go back to reference Rahib L, Smith BD, Aizenberg R, Rosenzweig AB, Fleshman JM, Matrisian LM. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res. 2014;74(11):2913–21.CrossRefPubMed Rahib L, Smith BD, Aizenberg R, Rosenzweig AB, Fleshman JM, Matrisian LM. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res. 2014;74(11):2913–21.CrossRefPubMed
7.
go back to reference Kilfoy BA, Zheng T, Holford TR, Han X, Ward MH, Sjodin A, Zhang Y, Bai Y, Zhu C, Guo GL. International patterns and trends in thyroid cancer incidence, 1973–2002. Cancer Causes Control. 2009;20(5):525–31.CrossRefPubMed Kilfoy BA, Zheng T, Holford TR, Han X, Ward MH, Sjodin A, Zhang Y, Bai Y, Zhu C, Guo GL. International patterns and trends in thyroid cancer incidence, 1973–2002. Cancer Causes Control. 2009;20(5):525–31.CrossRefPubMed
8.
go back to reference Wang Y, Wang W. Increasing incidence of thyroid cancer in Shanghai, China, 1983-2007. Asia Pac J Public Health. 2015;27(2):NP223–9.CrossRefPubMed Wang Y, Wang W. Increasing incidence of thyroid cancer in Shanghai, China, 1983-2007. Asia Pac J Public Health. 2015;27(2):NP223–9.CrossRefPubMed
9.
go back to reference Kent WD, Hall SF, Isotalo PA, Houlden RL, George RL, Groome PA. Increased incidence of differentiated thyroid carcinoma and detection of subclinical disease. Can Med Assoc J. 2007;177(11):1357–61.CrossRef Kent WD, Hall SF, Isotalo PA, Houlden RL, George RL, Groome PA. Increased incidence of differentiated thyroid carcinoma and detection of subclinical disease. Can Med Assoc J. 2007;177(11):1357–61.CrossRef
10.
go back to reference Chen AY, Jemal A, Ward EM. Increasing incidence of differentiated thyroid cancer in the United States, 1988–2005. Cancer. 2009;115(16):3801–7.CrossRefPubMed Chen AY, Jemal A, Ward EM. Increasing incidence of differentiated thyroid cancer in the United States, 1988–2005. Cancer. 2009;115(16):3801–7.CrossRefPubMed
11.
go back to reference Morris LG, Myssiorek D. Improved detection does not fully explain the rising incidence of well-differentiated thyroid cancer: a population-based analysis. Am J Surg. 2010;200(4):454–61.CrossRefPubMedPubMedCentral Morris LG, Myssiorek D. Improved detection does not fully explain the rising incidence of well-differentiated thyroid cancer: a population-based analysis. Am J Surg. 2010;200(4):454–61.CrossRefPubMedPubMedCentral
12.
go back to reference Enewold L, Zhu K, Ron E, Marrogi AJ, Stojadinovic A, Peoples GE, Devesa SS. Rising thyroid cancer incidence in the United States by demographic and tumor characteristics, 1980-2005. Cancer Epidemiol Biomark Prev. 2009;18(3):784–91.CrossRef Enewold L, Zhu K, Ron E, Marrogi AJ, Stojadinovic A, Peoples GE, Devesa SS. Rising thyroid cancer incidence in the United States by demographic and tumor characteristics, 1980-2005. Cancer Epidemiol Biomark Prev. 2009;18(3):784–91.CrossRef
13.
go back to reference Zhu C, Zheng T, Kilfoy BA, Han X, Ma S, Ba Y, Bai Y, Wang R, Zhu Y, Zhang Y. A birth cohort analysis of the incidence of papillary thyroid cancer in the United States, 1973–2004. Thyroid. 2009;19(10):1061–6.CrossRefPubMedPubMedCentral Zhu C, Zheng T, Kilfoy BA, Han X, Ma S, Ba Y, Bai Y, Wang R, Zhu Y, Zhang Y. A birth cohort analysis of the incidence of papillary thyroid cancer in the United States, 1973–2004. Thyroid. 2009;19(10):1061–6.CrossRefPubMedPubMedCentral
14.
go back to reference Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55(2):74–108.CrossRefPubMed Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55(2):74–108.CrossRefPubMed
15.
go back to reference Aschebrook-Kilfoy B, Schechter RB, Shih Y-CT, Kaplan EL, Chiu BC-H, Angelos P, Grogan RH. The clinical and economic burden of a sustained increase in thyroid cancer incidence. Cancer Epidemiol Prev Biomarkers. 2013;22(7):1252–9.CrossRef Aschebrook-Kilfoy B, Schechter RB, Shih Y-CT, Kaplan EL, Chiu BC-H, Angelos P, Grogan RH. The clinical and economic burden of a sustained increase in thyroid cancer incidence. Cancer Epidemiol Prev Biomarkers. 2013;22(7):1252–9.CrossRef
16.
go back to reference Fualal J, Ehrenkranz J. Access, availability, and infrastructure deficiency: the current management of thyroid disease in the developing world. Rev Endocr Metab Disord. 2016;17(4):583–9.CrossRefPubMed Fualal J, Ehrenkranz J. Access, availability, and infrastructure deficiency: the current management of thyroid disease in the developing world. Rev Endocr Metab Disord. 2016;17(4):583–9.CrossRefPubMed
17.
go back to reference Ahmad OB, Boschi-Pinto C, Lopez AD, Murray CJ, Lozano R, Inoue M. Age standardization of rates: a new WHO standard, vol. 9. Geneva: World Health Organization; 2001. Ahmad OB, Boschi-Pinto C, Lopez AD, Murray CJ, Lozano R, Inoue M. Age standardization of rates: a new WHO standard, vol. 9. Geneva: World Health Organization; 2001.
18.
go back to reference Joinpoint Regression Program V: Statistical methodology and applications branch. In. Surveillance Research Program, National Cancer Institute, USA.; 2017. Joinpoint Regression Program V: Statistical methodology and applications branch. In. Surveillance Research Program, National Cancer Institute, USA.; 2017.
19.
go back to reference Kim H-J, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med. 2000;19(3):335–51.CrossRefPubMed Kim H-J, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med. 2000;19(3):335–51.CrossRefPubMed
20.
go back to reference Ron E, Lubin JH, Shore RE, Mabuchi K, Modan B, Pottern LM, Schneider AB, Tucker MA, Boice JD Jr. Thyroid cancer after exposure to external radiation: a pooled analysis of seven studies. Radiat Res. 1995;141(3):259–77.CrossRefPubMed Ron E, Lubin JH, Shore RE, Mabuchi K, Modan B, Pottern LM, Schneider AB, Tucker MA, Boice JD Jr. Thyroid cancer after exposure to external radiation: a pooled analysis of seven studies. Radiat Res. 1995;141(3):259–77.CrossRefPubMed
21.
go back to reference Belfiore A, La Rosa GL, Padova G, Sava L, Ippolito O, Vigneri R. The frequency of cold thyroid nodules and thyroid malignancies in patients from an iodine-deficient area. Cancer. 1987;60(12):3096–102.CrossRefPubMed Belfiore A, La Rosa GL, Padova G, Sava L, Ippolito O, Vigneri R. The frequency of cold thyroid nodules and thyroid malignancies in patients from an iodine-deficient area. Cancer. 1987;60(12):3096–102.CrossRefPubMed
22.
go back to reference Repplinger D, Bargren A, Zhang Y-W, Adler JT, Haymart M, Chen H. Is Hashimoto’s thyroiditis a risk factor for papillary thyroid cancer? J Surg Res. 2008;150(1):49–52.CrossRefPubMed Repplinger D, Bargren A, Zhang Y-W, Adler JT, Haymart M, Chen H. Is Hashimoto’s thyroiditis a risk factor for papillary thyroid cancer? J Surg Res. 2008;150(1):49–52.CrossRefPubMed
23.
go back to reference Mathai V, Idikula J, Fenn A, Nair A. DO LONG-STANDING NODULAR GOITRES RESULT IN MALIGNANCIES? ANZ J Surg. 1994;64(3):180–2.CrossRef Mathai V, Idikula J, Fenn A, Nair A. DO LONG-STANDING NODULAR GOITRES RESULT IN MALIGNANCIES? ANZ J Surg. 1994;64(3):180–2.CrossRef
24.
go back to reference Mack WJ, Preston-Martin S, Dal Maso L, Galanti R, Xiang M, Franceschi S, Hallquist A, Jin F, Kolonel L, La Vecchia C. A pooled analysis of case–control studies of thyroid cancer: cigarette smoking and consumption of alcohol, coffee, and tea. Cancer Causes Control. 2003;14(8):773–85.CrossRefPubMed Mack WJ, Preston-Martin S, Dal Maso L, Galanti R, Xiang M, Franceschi S, Hallquist A, Jin F, Kolonel L, La Vecchia C. A pooled analysis of case–control studies of thyroid cancer: cigarette smoking and consumption of alcohol, coffee, and tea. Cancer Causes Control. 2003;14(8):773–85.CrossRefPubMed
25.
go back to reference Stjernswärd J. National training of radiotherapists in Sri Lanka and Zimbabwe: priorities and strategies for cancer control in developing countries. Int J Radiat Oncol Biol Phys. 1990;19(5):1275–8.CrossRefPubMed Stjernswärd J. National training of radiotherapists in Sri Lanka and Zimbabwe: priorities and strategies for cancer control in developing countries. Int J Radiat Oncol Biol Phys. 1990;19(5):1275–8.CrossRefPubMed
26.
go back to reference Jayatissa R, Gunathilaka M. Iodine nutrition status in Sri Lanka. Colombo: Medical Research Institute, Department of Healthcare and Nutrition; 2006. Jayatissa R, Gunathilaka M. Iodine nutrition status in Sri Lanka. Colombo: Medical Research Institute, Department of Healthcare and Nutrition; 2006.
27.
go back to reference Fernando R, Chandrasinghe P, Nandasena S, Pathmeswaran A. Epidemiology of Goitres in Sri Lanka with geographic information system mapping: a population based cross sectional study. World J Endocrine Surg. 2015;7(3):55–9. Fernando R, Chandrasinghe P, Nandasena S, Pathmeswaran A. Epidemiology of Goitres in Sri Lanka with geographic information system mapping: a population based cross sectional study. World J Endocrine Surg. 2015;7(3):55–9.
28.
go back to reference Fernando M, Balasuriya S, Herath K, Katugampola S. Endemic goitre in Sri Lanka. Asia Pac J Public Health. 1989;3(1):11–8.CrossRefPubMed Fernando M, Balasuriya S, Herath K, Katugampola S. Endemic goitre in Sri Lanka. Asia Pac J Public Health. 1989;3(1):11–8.CrossRefPubMed
29.
go back to reference Fernando R, Chandrasinghe P, Pathmeswaran A. The prevalence of autoimmune thyroiditis after universal salt iodisation in Sri Lanka. Ceylon Med J. 2012;57:116–9.CrossRefPubMed Fernando R, Chandrasinghe P, Pathmeswaran A. The prevalence of autoimmune thyroiditis after universal salt iodisation in Sri Lanka. Ceylon Med J. 2012;57:116–9.CrossRefPubMed
30.
go back to reference Wijeyaratne CN, Jayasinghe A, de Silva D, Parkes A, Lazarus J, Premawardhana L: Iodine prophylaxis, goitre and thyroid autoimmunity in Sri Lanka. 2005. Wijeyaratne CN, Jayasinghe A, de Silva D, Parkes A, Lazarus J, Premawardhana L: Iodine prophylaxis, goitre and thyroid autoimmunity in Sri Lanka. 2005.
31.
go back to reference Katulanda P, Jayawardena M, Sheriff M, Constantine G, Matthews D. Prevalence of overweight and obesity in Sri Lankan adults. Obes Rev. 2010;11(11):751–6.CrossRefPubMed Katulanda P, Jayawardena M, Sheriff M, Constantine G, Matthews D. Prevalence of overweight and obesity in Sri Lankan adults. Obes Rev. 2010;11(11):751–6.CrossRefPubMed
32.
go back to reference Pellegriti G, Frasca F, Regalbuto C, Squatrito S, Vigneri R. Worldwide increasing incidence of thyroid cancer: update on epidemiology and risk factors. J Cancer Epidemiol. 2013;2013:965212.CrossRefPubMedPubMedCentral Pellegriti G, Frasca F, Regalbuto C, Squatrito S, Vigneri R. Worldwide increasing incidence of thyroid cancer: update on epidemiology and risk factors. J Cancer Epidemiol. 2013;2013:965212.CrossRefPubMedPubMedCentral
33.
go back to reference Ahn HS, Kim HJ, Welch HG. Korea’s thyroid-cancer “epidemic”: screening and overdiagnosis. N Engl J Med. 2014;371(19):1765–7.CrossRefPubMed Ahn HS, Kim HJ, Welch HG. Korea’s thyroid-cancer “epidemic”: screening and overdiagnosis. N Engl J Med. 2014;371(19):1765–7.CrossRefPubMed
34.
go back to reference Ratnatunga P, Amarasinghe S, Ratnatunga N. Changing patterns of thyroid cancer in Sri Lanka. Has the iodination programme helped? Ceylon Med J. 2011;48(4):125-8. Ratnatunga P, Amarasinghe S, Ratnatunga N. Changing patterns of thyroid cancer in Sri Lanka. Has the iodination programme helped? Ceylon Med J. 2011;48(4):125-8.
35.
go back to reference Arem M, FACE, Ridha, Padayatty M, Sebastian J, Saliby M, Aida H, Sherman M, Steven I. Thyroid microcarcinoma: prevalence, prognosis, and management. Endocr Pract. 1999;5(3):148–56.CrossRefPubMed Arem M, FACE, Ridha, Padayatty M, Sebastian J, Saliby M, Aida H, Sherman M, Steven I. Thyroid microcarcinoma: prevalence, prognosis, and management. Endocr Pract. 1999;5(3):148–56.CrossRefPubMed
36.
go back to reference Harach HR, Franssila KO, Wasenius VM. Occult papillary carcinoma of the thyroid. A “normal” finding in Finland. A systematic autopsy study. Cancer. 1985;56(3):531–8.CrossRefPubMed Harach HR, Franssila KO, Wasenius VM. Occult papillary carcinoma of the thyroid. A “normal” finding in Finland. A systematic autopsy study. Cancer. 1985;56(3):531–8.CrossRefPubMed
37.
go back to reference De Silva K. Update on thyroid cancer management and the limitations faced by us. Sri Lanka J Diabetes Endocrinol Metab. 2012;2(1):21-4. De Silva K. Update on thyroid cancer management and the limitations faced by us. Sri Lanka J Diabetes Endocrinol Metab. 2012;2(1):21-4.
38.
go back to reference Seneviratne S, Prabhashani S, Fernando A. Incidence and histologic patterns of thyroid cancer in Sri Lanka 2001-2010. Eur J Cancer. 2017;72:S–104. Seneviratne S, Prabhashani S, Fernando A. Incidence and histologic patterns of thyroid cancer in Sri Lanka 2001-2010. Eur J Cancer. 2017;72:S–104.
Metadata
Title
Incidence and histological patterns of thyroid cancer in Sri Lanka 2001-2010: an analysis of national cancer registry data
Authors
Umesh Jayarajah
Ashan Fernando
Saumyakala Prabashani
Eshani A. Fernando
Sanjeewa A. Seneviratne
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2018
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-018-4083-5

Other articles of this Issue 1/2018

BMC Cancer 1/2018 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine